Cargando…

Risk Communication During COVID-19

During the unprecedented times caused by the novel coronavirus disease 2019, there is rapidly evolving information and guidance. However, a focus must also be on proper and effective risk communication. This is especially the case during pandemics that have high rates of infection, significant morbi...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrams, Elissa M., Greenhawt, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158804/
https://www.ncbi.nlm.nih.gov/pubmed/32304834
http://dx.doi.org/10.1016/j.jaip.2020.04.012
_version_ 1783522558670274560
author Abrams, Elissa M.
Greenhawt, Matthew
author_facet Abrams, Elissa M.
Greenhawt, Matthew
author_sort Abrams, Elissa M.
collection PubMed
description During the unprecedented times caused by the novel coronavirus disease 2019, there is rapidly evolving information and guidance. However, a focus must also be on proper and effective risk communication. This is especially the case during pandemics that have high rates of infection, significant morbidity, lack of therapeutic measures, and rapid increases in cases, all of which apply to the current coronavirus disease 2019 pandemic. A consequence of poor risk communication and heightened risk perception is hoarding behavior, which can lead to lack of medications and personal protective equipment. One potential way to ensure appropriate risk communication is using social media channels, and ensuring an ongoing consistent media presence. Another important step is to include all stakeholders including members of the allergy community in broader public health messaging. As we continue to face unprecedented times in the allergy community, an understanding and appreciation of risk communication will be essential as we communicate with, and inform, our patients, and our colleagues, moving forward.
format Online
Article
Text
id pubmed-7158804
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-71588042020-04-15 Risk Communication During COVID-19 Abrams, Elissa M. Greenhawt, Matthew J Allergy Clin Immunol Pract Article During the unprecedented times caused by the novel coronavirus disease 2019, there is rapidly evolving information and guidance. However, a focus must also be on proper and effective risk communication. This is especially the case during pandemics that have high rates of infection, significant morbidity, lack of therapeutic measures, and rapid increases in cases, all of which apply to the current coronavirus disease 2019 pandemic. A consequence of poor risk communication and heightened risk perception is hoarding behavior, which can lead to lack of medications and personal protective equipment. One potential way to ensure appropriate risk communication is using social media channels, and ensuring an ongoing consistent media presence. Another important step is to include all stakeholders including members of the allergy community in broader public health messaging. As we continue to face unprecedented times in the allergy community, an understanding and appreciation of risk communication will be essential as we communicate with, and inform, our patients, and our colleagues, moving forward. American Academy of Allergy, Asthma & Immunology 2020-06 2020-04-15 /pmc/articles/PMC7158804/ /pubmed/32304834 http://dx.doi.org/10.1016/j.jaip.2020.04.012 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Abrams, Elissa M.
Greenhawt, Matthew
Risk Communication During COVID-19
title Risk Communication During COVID-19
title_full Risk Communication During COVID-19
title_fullStr Risk Communication During COVID-19
title_full_unstemmed Risk Communication During COVID-19
title_short Risk Communication During COVID-19
title_sort risk communication during covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158804/
https://www.ncbi.nlm.nih.gov/pubmed/32304834
http://dx.doi.org/10.1016/j.jaip.2020.04.012
work_keys_str_mv AT abramselissam riskcommunicationduringcovid19
AT greenhawtmatthew riskcommunicationduringcovid19